Request for Information (RFI): Large Scale Clinical Trials on Aging

Notice Number: NOT-AG-10-005

Key Dates
Release Date:  April 5, 2010
Response Due Date:  September 3, 2010

Issued by
National Institute on Aging (NIA) (


The Division of Geriatrics and Clinical Gerontology (DGCG) at the National Institute on Aging (NIA) supports clinical trials on topics relating to aging and the elderly. Researchers with interest in trials whose direct costs are less than $2 million per year are encouraged to contact the Clinical Trials Branch staff at DGCG also invites suggestions from the scientific community regarding needs for large (over $2 million direct and/ or over $3 million total costs per year) clinical trials in topic areas relevant to DGCG’s mission.  NIA will use your suggestions in its planning process to select high priority topic areas in which significant existing knowledge indicates the need for large clinical trials to provide more definitive information on risks and benefits of interventions for diseases and conditions in the elderly.


The DGCG supports research on health and disease in the aged as well as research on aging over the human life span including its relationships to health outcomes. DGCG comprises three major research areas: Geriatrics, Clinical Gerontology, and Clinical Trials. The Geriatrics Branch primarily focuses on health issues regarding the aged. The Clinical Gerontology Branch focuses on clinically-related issues regarding aging changes over the life span. The Clinical Trials Branch plans and administers clinical trials on age-related issues with emphasis on:

More information about DGCG is available at


Your suggestions will assist the DGCG in planning for large scale clinical trials in topic areas relevant to its mission where existing evidence suggests the need for definitive information about the benefits and risks of interventions for diseases and conditions in the elderly.

Please provide suggestions addressing the following issues:

1.  Provide a brief description of the topic area and current state of science indicating the need for a large scale clinical trial or trials to obtain definitive information about the benefits and / or risks of intervention or interventions in elderly in the topic area.

2.  Define the prospective study population and briefly discuss a potential intervention or interventions and any preliminary information supporting the need for testing such an intervention or interventions in a large scale trial in the proposed population.  Drugs, devices, lifestyle modifications, and other interventions could be proposed.

3.  Provide a brief rationale for the selection of endpoints (clinical, functional, or surrogate). There is no need to propose specific outcome measures.

4.  Provide an estimate of sample size, duration and costs of trial(s).

5.  Provide any additional comments or suggestions that you think would be useful.


Please respond no later than September 3, 2010.  We look forward to your suggestions and hope you will share this document with your colleagues. 


To respond, please send your suggestions by a letter, fax, or email to the following address:

Sergei V. Romashkan, M.D., Ph.D.
Chief, Clinical Trials Branch
Geriatrics and Clinical Gerontology Program
National Institute on Aging
7201 Wisconsin Avenue, Suite 525A
Bethesda, MD 20892-9205
(Fed Ex Packages use ZIP 20814)
Phone: 301-435-3047
Fax: 301-480-1066

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.